Chairman, Chief Executive Officer & President, Eli Lilly and Company
Most recently reported pay: $8.9M. No year-by-year proxy breakdown is on file — common for foreign private issuers and recently listed companies, which do not file a US proxy statement.
Names, titles and pay as reported by the company and its SEC filings, via Financial Modeling Prep. Reference only — nothing here is investment advice, and no affiliation with or endorsement by the people listed is implied.
Nasdaq closes 1.38% lower on AI spending and inflation concerns
Oct 29, 2026https://invezz.com/news/2026/10/29/nasdaq-closes-1-38-lower-on-ai-spending-and-inflation-concerns/sentiment +0.60
Nasdaq falls 1.83% as Alphabet sell-off revives fears over AI spending costs
Oct 29, 2026https://invezz.com/news/2026/10/29/nasdaq-falls-1-83-as-alphabet-sell-off-revives-fears-over-ai-spending-costs/sentiment +0.70
Biotech stocks are surging. How investors can play the new drug innovation boom
Oct 24, 2026https://www.cnbc.com/2026/10/24/biotech-stocks-drug-innovation-rally.htmlsentiment +0.80
Dow rises 1% as earnings gains and lower oil prices lift Wall Street
Oct 20, 2026https://invezz.com/news/2026/10/20/dow-rises-1-as-earnings-gains-and-lower-oil-prices-lift-wall-street/sentiment +0.80
Stock Market Ends Week With Software Sell-Off; Nasdaq Dives 2%, Gives Up 200-Day Line
Oct 16, 2026https://www.investors.com/market-trend/the-big-picture/stock-market-ends-week-software-sell-off-nasdaq-dives/sentiment +0.80
Dow rises 556 points as investors rotate out of AI stocks on inflation fears
Oct 15, 2026https://invezz.com/news/2026/10/15/dow-rises-556-points-as-investors-rotate-out-of-ai-stocks-on-inflation-fears/sentiment +0.80
